nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ABCB1—ovarian cancer	0.433	1	CbGaD
Doxazosin—ABCB1—Topotecan—ovarian cancer	0.0465	0.267	CbGbCtD
Doxazosin—ABCB1—Vinorelbine—ovarian cancer	0.0327	0.188	CbGbCtD
Doxazosin—CYP2D6—Vinorelbine—ovarian cancer	0.0308	0.178	CbGbCtD
Doxazosin—ABCB1—Paclitaxel—ovarian cancer	0.023	0.132	CbGbCtD
Doxazosin—ABCB1—Docetaxel—ovarian cancer	0.0166	0.0957	CbGbCtD
Doxazosin—ABCB1—Doxorubicin—ovarian cancer	0.0124	0.0713	CbGbCtD
Doxazosin—CYP2D6—Doxorubicin—ovarian cancer	0.0117	0.0672	CbGbCtD
Doxazosin—KCNH7—testis—ovarian cancer	0.00305	0.0719	CbGeAlD
Doxazosin—KCNH6—uterus—ovarian cancer	0.00299	0.0706	CbGeAlD
Doxazosin—KCNH6—female reproductive system—ovarian cancer	0.00269	0.0635	CbGeAlD
Doxazosin—ADRA1D—epithelium—ovarian cancer	0.00201	0.0474	CbGeAlD
Doxazosin—ADRA1D—female reproductive system—ovarian cancer	0.00149	0.0352	CbGeAlD
Doxazosin—ORM1—endometrium—ovarian cancer	0.00148	0.035	CbGeAlD
Doxazosin—KCNH2—myometrium—ovarian cancer	0.00142	0.0335	CbGeAlD
Doxazosin—ORM1—female reproductive system—ovarian cancer	0.00123	0.029	CbGeAlD
Doxazosin—ORM1—bone marrow—ovarian cancer	0.00116	0.0273	CbGeAlD
Doxazosin—ADRA1A—epithelium—ovarian cancer	0.00115	0.0272	CbGeAlD
Doxazosin—ADRA2A—myometrium—ovarian cancer	0.00112	0.0263	CbGeAlD
Doxazosin—KCNH2—uterine cervix—ovarian cancer	0.0011	0.026	CbGeAlD
Doxazosin—Terazosin—ABCB1—ovarian cancer	0.00104	0.594	CrCbGaD
Doxazosin—KCNH2—endometrium—ovarian cancer	0.000998	0.0236	CbGeAlD
Doxazosin—KCNH2—uterus—ovarian cancer	0.00092	0.0217	CbGeAlD
Doxazosin—ADRA2A—uterine cervix—ovarian cancer	0.000869	0.0205	CbGeAlD
Doxazosin—ADRA2A—decidua—ovarian cancer	0.000828	0.0195	CbGeAlD
Doxazosin—KCNH2—female reproductive system—ovarian cancer	0.000827	0.0195	CbGeAlD
Doxazosin—ADRA2A—endometrium—ovarian cancer	0.000786	0.0185	CbGeAlD
Doxazosin—CYP2C19—vagina—ovarian cancer	0.000784	0.0185	CbGeAlD
Doxazosin—KCNH2—bone marrow—ovarian cancer	0.000781	0.0184	CbGeAlD
Doxazosin—KCNH2—female gonad—ovarian cancer	0.000752	0.0178	CbGeAlD
Doxazosin—KCNH2—vagina—ovarian cancer	0.000748	0.0176	CbGeAlD
Doxazosin—ADRA2A—gonad—ovarian cancer	0.000729	0.0172	CbGeAlD
Doxazosin—ADRA2A—uterus—ovarian cancer	0.000724	0.0171	CbGeAlD
Doxazosin—ORM1—lymph node—ovarian cancer	0.000718	0.0169	CbGeAlD
Doxazosin—Prazosin—ABCB1—ovarian cancer	0.000713	0.407	CrCbGaD
Doxazosin—KCNH2—testis—ovarian cancer	0.000667	0.0157	CbGeAlD
Doxazosin—ADRA2A—female reproductive system—ovarian cancer	0.000651	0.0154	CbGeAlD
Doxazosin—ABCB1—myometrium—ovarian cancer	0.000622	0.0147	CbGeAlD
Doxazosin—ABCB1—embryo—ovarian cancer	0.000598	0.0141	CbGeAlD
Doxazosin—ADRA2A—female gonad—ovarian cancer	0.000592	0.014	CbGeAlD
Doxazosin—ADRA2A—vagina—ovarian cancer	0.000589	0.0139	CbGeAlD
Doxazosin—ADRA2A—testis—ovarian cancer	0.000525	0.0124	CbGeAlD
Doxazosin—CYP2D6—female reproductive system—ovarian cancer	0.000504	0.0119	CbGeAlD
Doxazosin—ABCB1—epithelium—ovarian cancer	0.000488	0.0115	CbGeAlD
Doxazosin—ABCB1—uterine cervix—ovarian cancer	0.000484	0.0114	CbGeAlD
Doxazosin—KCNH2—lymph node—ovarian cancer	0.000484	0.0114	CbGeAlD
Doxazosin—ABCB1—decidua—ovarian cancer	0.000461	0.0109	CbGeAlD
Doxazosin—CYP2D6—female gonad—ovarian cancer	0.000459	0.0108	CbGeAlD
Doxazosin—ABCB1—endometrium—ovarian cancer	0.000438	0.0103	CbGeAlD
Doxazosin—CYP2D6—testis—ovarian cancer	0.000407	0.0096	CbGeAlD
Doxazosin—ABCB1—gonad—ovarian cancer	0.000406	0.00958	CbGeAlD
Doxazosin—ABCB1—uterus—ovarian cancer	0.000404	0.00952	CbGeAlD
Doxazosin—ADRA2A—lymph node—ovarian cancer	0.000381	0.00899	CbGeAlD
Doxazosin—ABCB1—female reproductive system—ovarian cancer	0.000363	0.00856	CbGeAlD
Doxazosin—ABCB1—bone marrow—ovarian cancer	0.000342	0.00808	CbGeAlD
Doxazosin—ABCB1—female gonad—ovarian cancer	0.00033	0.00779	CbGeAlD
Doxazosin—ABCB1—vagina—ovarian cancer	0.000328	0.00774	CbGeAlD
Doxazosin—ABCB1—testis—ovarian cancer	0.000293	0.00691	CbGeAlD
Doxazosin—Headache—Vinorelbine—ovarian cancer	0.000231	0.000661	CcSEcCtD
Doxazosin—Syncope—Docetaxel—ovarian cancer	0.000231	0.000661	CcSEcCtD
Doxazosin—Leukopenia—Docetaxel—ovarian cancer	0.000231	0.00066	CcSEcCtD
Doxazosin—Pollakiuria—Epirubicin—ovarian cancer	0.00023	0.00066	CcSEcCtD
Doxazosin—Palpitations—Docetaxel—ovarian cancer	0.000228	0.000652	CcSEcCtD
Doxazosin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000228	0.000652	CcSEcCtD
Doxazosin—Weight increased—Epirubicin—ovarian cancer	0.000227	0.00065	CcSEcCtD
Doxazosin—Loss of consciousness—Docetaxel—ovarian cancer	0.000226	0.000648	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000226	0.000647	CcSEcCtD
Doxazosin—Weight decreased—Epirubicin—ovarian cancer	0.000226	0.000646	CcSEcCtD
Doxazosin—Hyperglycaemia—Epirubicin—ovarian cancer	0.000225	0.000644	CcSEcCtD
Doxazosin—Cough—Docetaxel—ovarian cancer	0.000225	0.000644	CcSEcCtD
Doxazosin—Angina pectoris—Doxorubicin—ovarian cancer	0.000225	0.000643	CcSEcCtD
Doxazosin—Insomnia—Paclitaxel—ovarian cancer	0.000224	0.000642	CcSEcCtD
Doxazosin—Pneumonia—Epirubicin—ovarian cancer	0.000224	0.00064	CcSEcCtD
Doxazosin—Convulsion—Docetaxel—ovarian cancer	0.000223	0.000639	CcSEcCtD
Doxazosin—Paraesthesia—Paclitaxel—ovarian cancer	0.000223	0.000638	CcSEcCtD
Doxazosin—Hypertension—Docetaxel—ovarian cancer	0.000222	0.000637	CcSEcCtD
Doxazosin—Drowsiness—Epirubicin—ovarian cancer	0.000222	0.000637	CcSEcCtD
Doxazosin—Bronchitis—Doxorubicin—ovarian cancer	0.000222	0.000635	CcSEcCtD
Doxazosin—Dyspnoea—Paclitaxel—ovarian cancer	0.000221	0.000633	CcSEcCtD
Doxazosin—Somnolence—Paclitaxel—ovarian cancer	0.00022	0.000631	CcSEcCtD
Doxazosin—Myalgia—Docetaxel—ovarian cancer	0.000219	0.000628	CcSEcCtD
Doxazosin—Chest pain—Docetaxel—ovarian cancer	0.000219	0.000628	CcSEcCtD
Doxazosin—Arthralgia—Docetaxel—ovarian cancer	0.000219	0.000628	CcSEcCtD
Doxazosin—Nausea—Vinorelbine—ovarian cancer	0.000219	0.000627	CcSEcCtD
Doxazosin—Dyspepsia—Paclitaxel—ovarian cancer	0.000218	0.000625	CcSEcCtD
Doxazosin—Jaundice—Epirubicin—ovarian cancer	0.000217	0.00062	CcSEcCtD
Doxazosin—Conjunctivitis—Epirubicin—ovarian cancer	0.000216	0.000619	CcSEcCtD
Doxazosin—Urinary tract infection—Epirubicin—ovarian cancer	0.000216	0.000619	CcSEcCtD
Doxazosin—Dysuria—Doxorubicin—ovarian cancer	0.000216	0.000618	CcSEcCtD
Doxazosin—Neutropenia—Doxorubicin—ovarian cancer	0.000216	0.000618	CcSEcCtD
Doxazosin—Decreased appetite—Paclitaxel—ovarian cancer	0.000216	0.000617	CcSEcCtD
Doxazosin—Dry mouth—Docetaxel—ovarian cancer	0.000214	0.000614	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000214	0.000614	CcSEcCtD
Doxazosin—Fatigue—Paclitaxel—ovarian cancer	0.000214	0.000612	CcSEcCtD
Doxazosin—Sweating—Epirubicin—ovarian cancer	0.000213	0.00061	CcSEcCtD
Doxazosin—Pollakiuria—Doxorubicin—ovarian cancer	0.000213	0.00061	CcSEcCtD
Doxazosin—ABCB1—lymph node—ovarian cancer	0.000212	0.00501	CbGeAlD
Doxazosin—Constipation—Paclitaxel—ovarian cancer	0.000212	0.000607	CcSEcCtD
Doxazosin—Pain—Paclitaxel—ovarian cancer	0.000212	0.000607	CcSEcCtD
Doxazosin—Haematuria—Epirubicin—ovarian cancer	0.000212	0.000607	CcSEcCtD
Doxazosin—Confusional state—Docetaxel—ovarian cancer	0.000212	0.000607	CcSEcCtD
Doxazosin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000211	0.000603	CcSEcCtD
Doxazosin—Oedema—Docetaxel—ovarian cancer	0.00021	0.000602	CcSEcCtD
Doxazosin—Weight increased—Doxorubicin—ovarian cancer	0.00021	0.000601	CcSEcCtD
Doxazosin—Epistaxis—Epirubicin—ovarian cancer	0.00021	0.0006	CcSEcCtD
Doxazosin—Infection—Docetaxel—ovarian cancer	0.000209	0.000598	CcSEcCtD
Doxazosin—Weight decreased—Doxorubicin—ovarian cancer	0.000209	0.000598	CcSEcCtD
Doxazosin—Sinusitis—Epirubicin—ovarian cancer	0.000209	0.000597	CcSEcCtD
Doxazosin—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000208	0.000596	CcSEcCtD
Doxazosin—Pneumonia—Doxorubicin—ovarian cancer	0.000207	0.000592	CcSEcCtD
Doxazosin—Shock—Docetaxel—ovarian cancer	0.000207	0.000592	CcSEcCtD
Doxazosin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000206	0.000589	CcSEcCtD
Doxazosin—Drowsiness—Doxorubicin—ovarian cancer	0.000206	0.000589	CcSEcCtD
Doxazosin—Tachycardia—Docetaxel—ovarian cancer	0.000205	0.000587	CcSEcCtD
Doxazosin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000204	0.000585	CcSEcCtD
Doxazosin—Skin disorder—Docetaxel—ovarian cancer	0.000204	0.000585	CcSEcCtD
Doxazosin—Bradycardia—Epirubicin—ovarian cancer	0.000203	0.000582	CcSEcCtD
Doxazosin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000203	0.000581	CcSEcCtD
Doxazosin—Jaundice—Doxorubicin—ovarian cancer	0.000201	0.000574	CcSEcCtD
Doxazosin—Anorexia—Docetaxel—ovarian cancer	0.0002	0.000574	CcSEcCtD
Doxazosin—Rhinitis—Epirubicin—ovarian cancer	0.0002	0.000573	CcSEcCtD
Doxazosin—Conjunctivitis—Doxorubicin—ovarian cancer	0.0002	0.000573	CcSEcCtD
Doxazosin—Urinary tract infection—Doxorubicin—ovarian cancer	0.0002	0.000573	CcSEcCtD
Doxazosin—Hepatitis—Epirubicin—ovarian cancer	0.0002	0.000571	CcSEcCtD
Doxazosin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000199	0.000569	CcSEcCtD
Doxazosin—Pharyngitis—Epirubicin—ovarian cancer	0.000198	0.000567	CcSEcCtD
Doxazosin—Sweating—Doxorubicin—ovarian cancer	0.000197	0.000565	CcSEcCtD
Doxazosin—Urticaria—Paclitaxel—ovarian cancer	0.000197	0.000564	CcSEcCtD
Doxazosin—Hypotension—Docetaxel—ovarian cancer	0.000196	0.000562	CcSEcCtD
Doxazosin—Haematuria—Doxorubicin—ovarian cancer	0.000196	0.000562	CcSEcCtD
Doxazosin—Abdominal pain—Paclitaxel—ovarian cancer	0.000196	0.000561	CcSEcCtD
Doxazosin—Body temperature increased—Paclitaxel—ovarian cancer	0.000196	0.000561	CcSEcCtD
Doxazosin—Epistaxis—Doxorubicin—ovarian cancer	0.000194	0.000556	CcSEcCtD
Doxazosin—Sinusitis—Doxorubicin—ovarian cancer	0.000193	0.000553	CcSEcCtD
Doxazosin—Visual impairment—Epirubicin—ovarian cancer	0.000192	0.000551	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000192	0.000548	CcSEcCtD
Doxazosin—Insomnia—Docetaxel—ovarian cancer	0.00019	0.000544	CcSEcCtD
Doxazosin—Paraesthesia—Docetaxel—ovarian cancer	0.000189	0.00054	CcSEcCtD
Doxazosin—Bradycardia—Doxorubicin—ovarian cancer	0.000188	0.000538	CcSEcCtD
Doxazosin—Dyspnoea—Docetaxel—ovarian cancer	0.000187	0.000537	CcSEcCtD
Doxazosin—Somnolence—Docetaxel—ovarian cancer	0.000187	0.000535	CcSEcCtD
Doxazosin—Eye disorder—Epirubicin—ovarian cancer	0.000187	0.000534	CcSEcCtD
Doxazosin—Tinnitus—Epirubicin—ovarian cancer	0.000186	0.000533	CcSEcCtD
Doxazosin—Flushing—Epirubicin—ovarian cancer	0.000185	0.00053	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—ovarian cancer	0.000185	0.00053	CcSEcCtD
Doxazosin—Dyspepsia—Docetaxel—ovarian cancer	0.000185	0.00053	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—ovarian cancer	0.000185	0.000529	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000184	0.000526	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—ovarian cancer	0.000183	0.000525	CcSEcCtD
Doxazosin—Decreased appetite—Docetaxel—ovarian cancer	0.000183	0.000523	CcSEcCtD
Doxazosin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000183	0.000523	CcSEcCtD
Doxazosin—Fatigue—Docetaxel—ovarian cancer	0.000181	0.000519	CcSEcCtD
Doxazosin—Constipation—Docetaxel—ovarian cancer	0.00018	0.000515	CcSEcCtD
Doxazosin—Pain—Docetaxel—ovarian cancer	0.00018	0.000515	CcSEcCtD
Doxazosin—Chills—Epirubicin—ovarian cancer	0.000179	0.000513	CcSEcCtD
Doxazosin—Arrhythmia—Epirubicin—ovarian cancer	0.000178	0.00051	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—ovarian cancer	0.000178	0.00051	CcSEcCtD
Doxazosin—Asthenia—Paclitaxel—ovarian cancer	0.000178	0.00051	CcSEcCtD
Doxazosin—Alopecia—Epirubicin—ovarian cancer	0.000176	0.000505	CcSEcCtD
Doxazosin—Pruritus—Paclitaxel—ovarian cancer	0.000175	0.000502	CcSEcCtD
Doxazosin—Mental disorder—Epirubicin—ovarian cancer	0.000175	0.000501	CcSEcCtD
Doxazosin—Malnutrition—Epirubicin—ovarian cancer	0.000174	0.000497	CcSEcCtD
Doxazosin—Feeling abnormal—Docetaxel—ovarian cancer	0.000173	0.000496	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—ovarian cancer	0.000173	0.000494	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—ovarian cancer	0.000172	0.000493	CcSEcCtD
Doxazosin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000172	0.000492	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—ovarian cancer	0.000171	0.000491	CcSEcCtD
Doxazosin—Flatulence—Epirubicin—ovarian cancer	0.000171	0.00049	CcSEcCtD
Doxazosin—Tension—Epirubicin—ovarian cancer	0.00017	0.000488	CcSEcCtD
Doxazosin—Dysgeusia—Epirubicin—ovarian cancer	0.00017	0.000487	CcSEcCtD
Doxazosin—Diarrhoea—Paclitaxel—ovarian cancer	0.00017	0.000486	CcSEcCtD
Doxazosin—Nervousness—Epirubicin—ovarian cancer	0.000169	0.000483	CcSEcCtD
Doxazosin—Back pain—Epirubicin—ovarian cancer	0.000168	0.000481	CcSEcCtD
Doxazosin—Muscle spasms—Epirubicin—ovarian cancer	0.000167	0.000478	CcSEcCtD
Doxazosin—Body temperature increased—Docetaxel—ovarian cancer	0.000166	0.000476	CcSEcCtD
Doxazosin—Abdominal pain—Docetaxel—ovarian cancer	0.000166	0.000476	CcSEcCtD
Doxazosin—Chills—Doxorubicin—ovarian cancer	0.000166	0.000474	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—ovarian cancer	0.000165	0.000472	CcSEcCtD
Doxazosin—Dizziness—Paclitaxel—ovarian cancer	0.000164	0.00047	CcSEcCtD
Doxazosin—Vision blurred—Epirubicin—ovarian cancer	0.000164	0.000469	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—ovarian cancer	0.000163	0.000467	CcSEcCtD
Doxazosin—Mental disorder—Doxorubicin—ovarian cancer	0.000162	0.000463	CcSEcCtD
Doxazosin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000161	0.000462	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—ovarian cancer	0.000161	0.00046	CcSEcCtD
Doxazosin—Agitation—Epirubicin—ovarian cancer	0.00016	0.000457	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—ovarian cancer	0.000158	0.000454	CcSEcCtD
Doxazosin—Tension—Doxorubicin—ovarian cancer	0.000158	0.000452	CcSEcCtD
Doxazosin—Vomiting—Paclitaxel—ovarian cancer	0.000158	0.000452	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—ovarian cancer	0.000157	0.000451	CcSEcCtD
Doxazosin—Malaise—Epirubicin—ovarian cancer	0.000157	0.000449	CcSEcCtD
Doxazosin—Rash—Paclitaxel—ovarian cancer	0.000156	0.000448	CcSEcCtD
Doxazosin—Dermatitis—Paclitaxel—ovarian cancer	0.000156	0.000447	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—ovarian cancer	0.000156	0.000447	CcSEcCtD
Doxazosin—Vertigo—Epirubicin—ovarian cancer	0.000156	0.000447	CcSEcCtD
Doxazosin—Syncope—Epirubicin—ovarian cancer	0.000156	0.000446	CcSEcCtD
Doxazosin—Leukopenia—Epirubicin—ovarian cancer	0.000156	0.000445	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—ovarian cancer	0.000156	0.000445	CcSEcCtD
Doxazosin—Headache—Paclitaxel—ovarian cancer	0.000155	0.000445	CcSEcCtD
Doxazosin—Hypersensitivity—Docetaxel—ovarian cancer	0.000155	0.000443	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—ovarian cancer	0.000155	0.000443	CcSEcCtD
Doxazosin—Palpitations—Epirubicin—ovarian cancer	0.000154	0.00044	CcSEcCtD
Doxazosin—Loss of consciousness—Epirubicin—ovarian cancer	0.000153	0.000437	CcSEcCtD
Doxazosin—Cough—Epirubicin—ovarian cancer	0.000152	0.000434	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—ovarian cancer	0.000152	0.000434	CcSEcCtD
Doxazosin—Asthenia—Docetaxel—ovarian cancer	0.000151	0.000432	CcSEcCtD
Doxazosin—Convulsion—Epirubicin—ovarian cancer	0.000151	0.000431	CcSEcCtD
Doxazosin—Hypertension—Epirubicin—ovarian cancer	0.00015	0.000429	CcSEcCtD
Doxazosin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000149	0.000427	CcSEcCtD
Doxazosin—Pruritus—Docetaxel—ovarian cancer	0.000149	0.000426	CcSEcCtD
Doxazosin—Myalgia—Epirubicin—ovarian cancer	0.000148	0.000424	CcSEcCtD
Doxazosin—Chest pain—Epirubicin—ovarian cancer	0.000148	0.000424	CcSEcCtD
Doxazosin—Arthralgia—Epirubicin—ovarian cancer	0.000148	0.000424	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—ovarian cancer	0.000148	0.000423	CcSEcCtD
Doxazosin—Anxiety—Epirubicin—ovarian cancer	0.000147	0.000422	CcSEcCtD
Doxazosin—Nausea—Paclitaxel—ovarian cancer	0.000147	0.000422	CcSEcCtD
Doxazosin—Discomfort—Epirubicin—ovarian cancer	0.000146	0.000418	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—ovarian cancer	0.000145	0.000415	CcSEcCtD
Doxazosin—Dry mouth—Epirubicin—ovarian cancer	0.000145	0.000414	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—ovarian cancer	0.000144	0.000414	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—ovarian cancer	0.000144	0.000413	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—ovarian cancer	0.000144	0.000412	CcSEcCtD
Doxazosin—Diarrhoea—Docetaxel—ovarian cancer	0.000144	0.000412	CcSEcCtD
Doxazosin—Confusional state—Epirubicin—ovarian cancer	0.000143	0.000409	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—ovarian cancer	0.000142	0.000407	CcSEcCtD
Doxazosin—Oedema—Epirubicin—ovarian cancer	0.000142	0.000406	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000141	0.000405	CcSEcCtD
Doxazosin—Infection—Epirubicin—ovarian cancer	0.000141	0.000403	CcSEcCtD
Doxazosin—Cough—Doxorubicin—ovarian cancer	0.00014	0.000402	CcSEcCtD
Doxazosin—Shock—Epirubicin—ovarian cancer	0.00014	0.000399	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—ovarian cancer	0.000139	0.000399	CcSEcCtD
Doxazosin—Dizziness—Docetaxel—ovarian cancer	0.000139	0.000398	CcSEcCtD
Doxazosin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000139	0.000398	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—ovarian cancer	0.000139	0.000397	CcSEcCtD
Doxazosin—Tachycardia—Epirubicin—ovarian cancer	0.000138	0.000396	CcSEcCtD
Doxazosin—Skin disorder—Epirubicin—ovarian cancer	0.000138	0.000394	CcSEcCtD
Doxazosin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000137	0.000392	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—ovarian cancer	0.000137	0.000392	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—ovarian cancer	0.000137	0.000392	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—ovarian cancer	0.000137	0.000392	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—ovarian cancer	0.000136	0.000391	CcSEcCtD
Doxazosin—Discomfort—Doxorubicin—ovarian cancer	0.000135	0.000387	CcSEcCtD
Doxazosin—Anorexia—Epirubicin—ovarian cancer	0.000135	0.000387	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—ovarian cancer	0.000134	0.000383	CcSEcCtD
Doxazosin—Vomiting—Docetaxel—ovarian cancer	0.000134	0.000383	CcSEcCtD
Doxazosin—Rash—Docetaxel—ovarian cancer	0.000133	0.00038	CcSEcCtD
Doxazosin—Hypotension—Epirubicin—ovarian cancer	0.000133	0.000379	CcSEcCtD
Doxazosin—Dermatitis—Docetaxel—ovarian cancer	0.000132	0.000379	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—ovarian cancer	0.000132	0.000379	CcSEcCtD
Doxazosin—Headache—Docetaxel—ovarian cancer	0.000132	0.000377	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—ovarian cancer	0.000131	0.000376	CcSEcCtD
Doxazosin—Infection—Doxorubicin—ovarian cancer	0.00013	0.000373	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000129	0.00037	CcSEcCtD
Doxazosin—Shock—Doxorubicin—ovarian cancer	0.000129	0.00037	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000128	0.000368	CcSEcCtD
Doxazosin—Insomnia—Epirubicin—ovarian cancer	0.000128	0.000367	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—ovarian cancer	0.000128	0.000367	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—ovarian cancer	0.000127	0.000365	CcSEcCtD
Doxazosin—Paraesthesia—Epirubicin—ovarian cancer	0.000127	0.000365	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000127	0.000363	CcSEcCtD
Doxazosin—Dyspnoea—Epirubicin—ovarian cancer	0.000126	0.000362	CcSEcCtD
Doxazosin—Somnolence—Epirubicin—ovarian cancer	0.000126	0.000361	CcSEcCtD
Doxazosin—Anorexia—Doxorubicin—ovarian cancer	0.000125	0.000358	CcSEcCtD
Doxazosin—Nausea—Docetaxel—ovarian cancer	0.000125	0.000358	CcSEcCtD
Doxazosin—Dyspepsia—Epirubicin—ovarian cancer	0.000125	0.000357	CcSEcCtD
Doxazosin—Decreased appetite—Epirubicin—ovarian cancer	0.000123	0.000353	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—ovarian cancer	0.000123	0.000351	CcSEcCtD
Doxazosin—Fatigue—Epirubicin—ovarian cancer	0.000122	0.00035	CcSEcCtD
Doxazosin—Pain—Epirubicin—ovarian cancer	0.000121	0.000347	CcSEcCtD
Doxazosin—Constipation—Epirubicin—ovarian cancer	0.000121	0.000347	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00012	0.000342	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—ovarian cancer	0.000119	0.00034	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—ovarian cancer	0.000118	0.000337	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—ovarian cancer	0.000117	0.000335	CcSEcCtD
Doxazosin—Feeling abnormal—Epirubicin—ovarian cancer	0.000117	0.000335	CcSEcCtD
Doxazosin—Somnolence—Doxorubicin—ovarian cancer	0.000117	0.000334	CcSEcCtD
Doxazosin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000116	0.000332	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—ovarian cancer	0.000115	0.000331	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—ovarian cancer	0.000114	0.000327	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—ovarian cancer	0.000113	0.000324	CcSEcCtD
Doxazosin—Urticaria—Epirubicin—ovarian cancer	0.000113	0.000323	CcSEcCtD
Doxazosin—Pain—Doxorubicin—ovarian cancer	0.000112	0.000321	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—ovarian cancer	0.000112	0.000321	CcSEcCtD
Doxazosin—Abdominal pain—Epirubicin—ovarian cancer	0.000112	0.000321	CcSEcCtD
Doxazosin—Body temperature increased—Epirubicin—ovarian cancer	0.000112	0.000321	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000108	0.00031	CcSEcCtD
Doxazosin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000107	0.000307	CcSEcCtD
Doxazosin—Hypersensitivity—Epirubicin—ovarian cancer	0.000104	0.000299	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—ovarian cancer	0.000104	0.000298	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—ovarian cancer	0.000104	0.000297	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—ovarian cancer	0.000104	0.000297	CcSEcCtD
Doxazosin—Asthenia—Epirubicin—ovarian cancer	0.000102	0.000291	CcSEcCtD
Doxazosin—Pruritus—Epirubicin—ovarian cancer	0.0001	0.000287	CcSEcCtD
Doxazosin—Diarrhoea—Epirubicin—ovarian cancer	9.7e-05	0.000278	CcSEcCtD
Doxazosin—Hypersensitivity—Doxorubicin—ovarian cancer	9.67e-05	0.000277	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—ovarian cancer	9.41e-05	0.00027	CcSEcCtD
Doxazosin—Dizziness—Epirubicin—ovarian cancer	9.38e-05	0.000268	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—ovarian cancer	9.28e-05	0.000266	CcSEcCtD
Doxazosin—Vomiting—Epirubicin—ovarian cancer	9.02e-05	0.000258	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—ovarian cancer	8.98e-05	0.000257	CcSEcCtD
Doxazosin—Rash—Epirubicin—ovarian cancer	8.94e-05	0.000256	CcSEcCtD
Doxazosin—Dermatitis—Epirubicin—ovarian cancer	8.93e-05	0.000256	CcSEcCtD
Doxazosin—Headache—Epirubicin—ovarian cancer	8.88e-05	0.000254	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—ovarian cancer	8.68e-05	0.000248	CcSEcCtD
Doxazosin—Nausea—Epirubicin—ovarian cancer	8.42e-05	0.000241	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—ovarian cancer	8.34e-05	0.000239	CcSEcCtD
Doxazosin—Rash—Doxorubicin—ovarian cancer	8.27e-05	0.000237	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—ovarian cancer	8.27e-05	0.000237	CcSEcCtD
Doxazosin—Headache—Doxorubicin—ovarian cancer	8.22e-05	0.000235	CcSEcCtD
Doxazosin—Nausea—Doxorubicin—ovarian cancer	7.79e-05	0.000223	CcSEcCtD
